Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate

Phase 4 Terminated 414 enrolled Teva Branded Pharmaceutical Products R&D, Inc.

RandomizedParallel-groupDouble-blindTreatment

This is a study evaluating the effect on brain volume of daily glatiramer acetate (GA) and add-on pulse steroids.

Evaluation	Drug	Modality	Dose	Route
Subject	Prednisone	Other / unclassified	1250 mg	—
Background	Glatiramer Acetate	Small molecule	10 mg	Subcutaneous
Background	Glatiramer Acetate	Small molecule	20 mg	Subcutaneous